After months of canceled, reinstated, and delayed orders in early 2025, a producer of fortified peanut-based pastes for treating child malnutrition has had its government contracts extended and renewed. By March 2026, production and shipments had returned to normal levels.
Date: 3/26
Region: Global
Country: Global
Topic: Food & Farming
Policy Lens: Global Health Security
Entry Type: Operational Impact
Additional Context: The U.S. has long funded half of the world’s supply of Ready-to-Use Therapeutic Foods, or RUTFs, with most of that portion manufactured by two organizations. Based in Georgia, Mana Nutrition produces Lipid-based Nutrient Supplements, or LNS, including RUTFs, used to treat severe acute malnutrition in children, and Ready-to-Use Supplementary Foods, or RUSFs, used to treat moderate acute malnutrition. While 320,000 boxes remained sitting in Mana’s warehouse in May 2025, as of March 2026 renewed contracts have operations moving normally.
Source: Mana Nutrition